Philip Astley-Sparke
Fundador en REPLIMUNE GROUP, INC. .
Fortuna: 9 M $ al 30/04/2024
Cargos activos de Philip Astley-Sparke
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REPLIMUNE GROUP, INC. | Presidente | 01/04/2024 | - |
| Fundador | 01/03/2015 | - | |
| Director/Miembro de la Junta | 01/03/2015 | 01/04/2024 | |
| Director Ejecutivo | 09/01/2020 | 01/04/2024 | |
| Secretario Corporativo | 01/03/2015 | - | |
| Treasurer | 01/03/2015 | - | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Inversor de Capital Privado | 01/05/2012 | - |
Replimune Ltd.
 Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Director/Miembro de la Junta | 18/03/2015 | - |
Historial de carrera de Philip Astley-Sparke
Antiguos cargos conocidos de Philip Astley-Sparke.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| UNIQURE N.V. | Director/Miembro de la Junta | 01/06/2015 | 22/09/2016 |
| Presidente | 22/09/2016 | 15/06/2021 | |
| Independent Dir/Board Member | - | 15/06/2021 | |
| Corporate Officer/Principal | 01/06/2013 | 22/09/2016 | |
| Oxyrane, Ltd. | Presidente | 01/01/2012 | 01/01/2020 |
uniQure, Inc.
 uniQure, Inc. BiotechnologyHealth Technology Part of uniQure NV, uniQure, Inc. provides research and development services of human gene based therapies. The company is based in Lexington, MA. | Presidente | 01/01/2013 | 01/02/2015 |
| AMGEN INC. | Corporate Officer/Principal | - | 01/12/2011 |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Director Ejecutivo | 01/07/2000 | 31/03/2011 |
| Presidente | 01/07/2000 | 31/03/2011 | |
| FORN EUROPAR | Director/Miembro de la Junta | - | - |
| Independent Dir/Board Member | - | - | |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Philip Astley-Sparke.
| University of Bristol | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Reino Unido | 3 |
| Países Bajos | 3 |
Operativa
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectorial
| Health Technology | 7 |
| Finance | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| UNIQURE N.V. | Health Technology |
| REPLIMUNE GROUP, INC. | Health Technology |
| Empresas privadas | 7 |
|---|---|
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
| Oxyrane, Ltd. | |
Replimune Ltd.
Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Commercial Services |
Forbion European Acquisition Corp.
 Forbion European Acquisition Corp. Financial ConglomeratesFinance Forbion European Acquisition Corp. is a blank check company. It engages in the business of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded by Hugo Alexander Slootweg in 2006 and is headquartered in Wilmington, DE. | Finance |
uniQure, Inc.
uniQure, Inc. BiotechnologyHealth Technology Part of uniQure NV, uniQure, Inc. provides research and development services of human gene based therapies. The company is based in Lexington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Philip Astley-Sparke
- Experiencia